Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-46.8%Return on Equity
VS
Market
Sector
Industry
History
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information
Ticker
RLAYCompany Name
RELAY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELAY THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLAY - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 665.66M | $ -311.55M | -46.8% |
| 3/31/2025 | $ 721.08M | $ -333.39M | -46.23% |
| 12/31/2024 | $ 777.79M | $ -337.71M | -43.42% |
| 9/30/2024 | $ 838.86M | $ -345.2M | -41.15% |
| 6/30/2024 | $ 681.74M | $ -322.83M | -47.35% |
| 3/31/2024 | $ 745.76M | $ -329.12M | -44.13% |
| 12/31/2023 | $ 752M | $ -341.97M | -45.47% |
| 9/30/2023 | $ 778.37M | $ -325.98M | -41.88% |
| 6/30/2023 | $ 810.12M | $ -344.42M | -42.51% |
| 3/31/2023 | $ 883.41M | $ -322.7M | -36.53% |
Key Performance Insights, Last 5 Years
- RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, RELAY THERAPEUTICS INC's average ROE has been -41.69%.
- The median ROE for RELAY THERAPEUTICS INC during this period was -42.51%
- RELAY THERAPEUTICS INC reached its highest ROE over the past 5 years at -29.05%.
- The lowest ROE recorded by RELAY THERAPEUTICS INC in the same timeframe -66.96%
RELAY THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for RELAY THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 713.52M ]
(=) ROE [ 0% ] RLAY - Return on Equity, Last 5 years
-66.96%
Minimum
Jun 30, 2021
-29.05%
Maximum
Sep 30, 2022
-41.69%
Average
-42.51%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |